Screening for Celiac Disease among Patients with Chronic Kidney Disease

Basit Öğe Kaydı
dc.authoridSahin, Idris/0000-0002-8683-3737
dc.authorwosidTuncer, Ilyas/L-3470-2013
dc.authorwosidSahin, Idris/AAS-4390-2020
dc.contributor.authorSahin, Idris
dc.contributor.authorEminbeyli, Lokman
dc.contributor.authorAndic, Safak
dc.contributor.authorTuncer, Ilyas
dc.contributor.authorKoz, Suleyman
dc.date.accessioned2024-08-04T20:35:52Z
dc.date.available2024-08-04T20:35:52Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: Celiac disease (CD) is considered to be a risk factor for chronic kidney disease (CKD) but there is no study determining the prevalence of CD, among patients with CKD. We aim to determine the prevalence of CD in patients with CKD. Materials and methods: Anti-endomysial IgA (EMA) antibody was screened in patients with CKD (glomerular filtration rate <60 mL/min). Patients who were EMA positive underwent upper gastrointestinal system endoscopy and intestinal biopsy for confirmation of definite diagnosis for CD. Results: Two hundred and ninety-two patients (161 males, mean age was 47.3 +/- 16.3 years) with CKD were included. The EMA testing was positive in 10 patients (6F/4M). Of these, eight underwent upper gastrointestinal endoscopy and biopsies, two of them rejected endoscopy. Biopsy specimen of one of the patients was not appropriate for histopathological examination. Specimens of remaining cases (4F/3M) were compatible with CD on histopathological examination. The EMA-positive CKD patients were 3.42% (1/29 cases) and frequency of CD was 2.39% (1/42 cases). Frequency of CD was 3.1% in females and 1.85% in males. Female/male ratio was 1.67. We did not find statistically significant difference between two groups according to age and gender. Apparent chronic gastrointestinal symptoms such as abdominal pain, distension, constipation, dyspepsia, and diarrhea were absent in patients diagnosed with CD. Differences between some laboratory parameters (such as complete blood count, albumin, calcium, phosphate, total cholesterol, ferritin, parathormone) of CD and non-CD patients were not significant statistically. Conclusion: Our results showed increased frequency of CD among patients with CKD and screening for CD in CKD population can be helpful.en_US
dc.identifier.doi10.3109/0886022X.2012.669299
dc.identifier.endpage549en_US
dc.identifier.issn0886-022X
dc.identifier.issue5en_US
dc.identifier.pmid22563918en_US
dc.identifier.scopus2-s2.0-84860738706en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage545en_US
dc.identifier.urihttps://doi.org/10.3109/0886022X.2012.669299
dc.identifier.urihttps://hdl.handle.net/11616/95645
dc.identifier.volume34en_US
dc.identifier.wosWOS:000303834600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofRenal Failureen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectceliac diseaseen_US
dc.subjectprevalenceen_US
dc.subjectchronic kidney diseaseen_US
dc.subjectanti-endomysial IgA antibodyen_US
dc.titleScreening for Celiac Disease among Patients with Chronic Kidney Diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu